Drug lookup
Drug reference

pefloxacin

Fluoroquinolone · Antibacterial

FluoroquinoloneAntibacterialATC null
CDSCO approved
EXCRETION
not curated
INTERACTIONS
2 major
SEVERE in our sources
PREGNANCY
X
FDA category + note
Top interactions
  • TheophyllineSevereTextbook-citedKDT 7e · p948
  • WarfarinSevereTextbook-citedKDT 7e · p948

Mechanism

null

Indications

meningeal infections (preferred due to greater CSF passage)many systemic infections

Dosing

Adult
400 mg BD (oral, with meals); 400 mg (i.v., dilute in glucose solution, not saline)
Hepatic adjustment
Drugs to be avoided

Pharmacokinetics

Half-life
8–14 hr
Bioavailability
90–100%
Protein binding
20–30%
Metabolism
85% (partly to norfloxacin, which contributes to activity)
Excretion
accumulates on repeated dosing

Contraindications

  • Liver disease
  • gram-positive coccal and Listeria infections (less effective)

Pregnancy & lactation

Pregnancy

X

Drug interactions

Theophylline
Severe
Textbook-cited

Theophylline toxicity (nausea, seizures, arrhythmias)

Monitor theophylline levels and reduce dose

Source: KDT 7e · p948

Warfarin
Severe
Textbook-cited

Increased anticoagulant effect and bleeding risk

Monitor INR and reduce warfarin dose

Source: KDT 7e · p948

Related guidelines

Other Fluoroquinolone drugs

Ask House about pefloxacin

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team